Allianz Expands Private-Client Menu While Claims Severity and Bond Risk Take Center Stage
Published on 10/11/2026 at 08:02 | Editorial boerse-global.de
Allianz is broadening its retail offering on two fronts while a fresh claims study and an analyst note put the insurance group's risk profile under the microscope. The insurer rolled out a paid telephone legal-advice line on October 5, and its private health arm had already launched a new inpatient supplementary product, "MeinKrankenhausschutz," on October 1 — a pair of moves that widen customer choice without yet settling any question about earnings.
The legal service carries a price tag of EUR 8.90 a year and is aimed squarely at registered private clients who do not already hold legal-expenses cover. Entitled policyholders can draw on up to two consultations per insurance year with partner attorneys. That eligibility restriction is deliberate: it fences off the target group, and the annual fee buys a capped number of phone consultations rather than unlimited access. For investors, the significance lies less in the fee than in the addressable base — Allianz is opening a route to legal advice for customers outside its existing legal-protection book.
The hospital product takes a different tack. "MeinKrankenhausschutz," introduced by Allianz Private Krankenversicherungs-AG, comes in three tariff tiers. Certain existing customers can switch into the new plans without a health check until December 31, 2026 — a transition window that forms a central part of the rollout, though it is not open to the entire back book. Which customers actually qualify for the simplified switch matters as much as the tier selection itself.
Claims Severity Climbs at Roughly 30% a Year
Separately, Allianz Commercial reported Thursday that the average cost per business-interruption claim has risen by about 30% annually over the past two years. The findings rest on 7,888 business-interruption insurance claims filed between January 1, 2021 and December 31, 2025, giving the study a multi-year span rather than a snapshot of a handful of large losses.
Should investors sell immediately? Or is it worth buying Allianz?
The aggregate value of the claims examined stands at roughly EUR 6.74 billion. That figure and the 30% annual increase in average severity measure different things: one captures the volume of losses studied, the other tracks more recent cost trends per case. The distinction matters for anyone assessing Allianz, because a report on insurance claims is not the same as a group income statement. A rising average does not by itself say anything concrete about profit — but it does explain why claims development belongs in any read on the insurance business.
Jefferies Lifts Target, Keeps Hold Rating
Capital allocation offers a second lens on risk. Jefferies raised its price target for Allianz to EUR 440 from EUR 420 on Thursday, while leaving its rating at "Hold" — meaning the higher marker did not come with a more favorable recommendation. Analyst Philip Kett tied the adjustment to realized gains from Allianz's Indian joint venture, which the insurer is reinvesting at an accelerated pace into fixed-income securities. Given persistent volatility in bond markets, Kett flagged the possibility of losses on such paper at other insurers as well.
Two distinct risk perspectives thus sit side by side: climbing costs on individual claims and potential markdowns on securities. The India proceeds are a positive factor, but the reinvestment turns attention squarely toward how bond markets behave.
Allianz at a turning point? This analysis reveals what investors need to know now.
November 12 Results Loom as the Next Yardstick
The next quarterly figures are due on November 12, 2026, giving investors their next concrete anchor for judging how the business is actually performing. Until then, the new retail products and the claims data merely round out the operating picture. Neither the legal-advice line nor the hospital tariffs, on their own, justifies a fresh valuation of the stock — and the key task at the November update will be separating the industry-wide claims backdrop and the capital-investment considerations from what Allianz actually reports.
Ad
Allianz Stock: New Analysis - 11 October
Fresh Allianz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
